Alzamend Neuro Overview

Alzamend Neuro Operating Income

Operating Income for ALZN.

Quarterly Operating Income

$-2197654.00

↑ 111.84% YoY

As of Jan 31, 2026

Annual Operating Income (TTM)

$-7034900.00

↑ 67.18% YoY

Trailing 12 months ending Jan 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin